 Home > Biochemistry News > Biotechnology News > Significantly improve the motor symptoms of patients with Parkinson's disease, phase 2 clinical results are positive

Significantly improve the motor symptoms of patients with Parkinson's disease, phase 2 clinical results are positive

 Last Update: 2021-09-06
 Source: Internet
 Author: User

Tags

tretinoin mechanism action

diagnose lyme disease

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Anavex Life Sciences announced that its investigational therapy Anavex 2-73 has achieved positive results in a Phase 2 clinical trial for patients with Parkinson's disease dementia

Anavex 2-73 is a sigma-1 receptor (SIGMAR1) agonist

In this phase 2 randomized, double-blind, placebo-controlled phase 2 clinical trial, 132 patients with Parkinson's disease dementia received different doses of Anavex 2-73 or placebo

The results of the trial showed that compared with placebo, the MDS-UPDRS (a score for evaluating the motor function of patients with Parkinson's disease) in the Anavex 2-73 high-dose group showed a statistically significant improvement

Anavex 2-73 treatment also resulted in a significant increase in SIGMAR1 mRNA expression (p=0.

"This is currently the second independent phase 2 clinical trial to

Reference materials:

[1] Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial for the Treatment of Patients with Parkinson's Disease Dementia.

[2] Anavex Corporate Presentation.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.